Carregant...
A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vector
Active vaccination strategies using viral vectors often give disappointing protection from tumor development, and usually requires multiple immunizations. These approaches normally use viruses that cause acute infections, as they provoke potent CD8 T cell responses. Persistent virus vectors have not...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2838928/ https://ncbi.nlm.nih.gov/pubmed/19921188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-009-0790-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|